Aurobindo Pharma Q3 net profit at Rs 534.95 croreAurobindo Pharma today reported a consolidated net profit at Rs 534.95 crore for the third quarter ended December 31, 2015.
Aurobindo Pharma targets a revenue of over $3 billion by 2017-18Aurobindo Pharma is targeting a revenue of over $3 billion (over Rs 19,800 crore) by 2017-18 and plans to expand its basket with drugs to t...
Aurobindo Pharma to expand product basket; eyes $3 billion revenues by FY18Aurobindo is targetting a revenue of over $ 3 billion by 2017-18 and plans to expand its basket with new drugs to treat cancer.
Plethico to pay Aurobindo Pharma $23.3 million to settle disputePlethico USA had not fulfilled obligations while selling Natrol to Aurobindo Pharma USA, hence they have to pay a penalty.
India, US struck 38 merger and acquisition deals worth $1.1 billion in 2014US' share in India's total outward FDI has increased to 7.8 per cent in 2014 from 5.5 per cent in 2009.
Pharma in 2014: Deals worth billions and fines worth millionsRanbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...
Aurobindo Pharma completes $132.5-million Natrol acquisitionAurobindo Pharma has completed acquisition of assets of nutritional supplement maker Natrol Inc and its other affiliate entities for $ 132....
Aurobindo Pharma highest bidder for NatrolThe nutritional supplement maker, bought by Plethico in 2008 for about $82 million, had filed a bankruptcy application in June in the wake ...
Aurobindo Pharma shares up over 3 per cent on bidding newsShares of Aurobindo Pharma rose by over 3 per cent today after the company announced that it emerged as the highest bidder for acquisition ...
Aurobindo Pharma emerges top bidder to buy Natrol Inc for $132.5 millionThe process of acquisition is based on an auction and with an agreement to take on certain liabilities of the US firm.
- Plethico shares climb 9 % on acquisition plans
Plethico Pharmaceuticals rose over 9 per cent after the drugmaker said it was eying acquisitions in the United States and Brazil for $150 m...
- Emkay recommends 'buy' on Plethico Pharma
Emkay Research has recommended ‘buy’ on Plethico Pharmaceutical for a target price of Rs 569. The stock currently trades at 9.9 times 2007-...
- Deal street buzzing with M&As worth $50bn
Of the 58 Merger and acquisitions struck in November alone by India Inc, cross-border deals cornered a lion's share. 11 tips to grow beyond...
- Plethico Pharma acquires US-based Natrol
Plethico Pharmaceuticals on Monday said it will acquire US-based Natrol Inc for 80.7 million dollars (Rs 317.07 crore) to consolidate its p...
- Plethico up 7.7% on Natrol acquisition
Plethico Pharmaceuticals Ltd shot up 7.71 per cent to Rs 502 on BSE after the company said Monday it has acquired Natrol Inc, a leading man...